Identification of Tumor Antigens in the HLA Peptidome of Patient-derived Xenograft Tumors in Mouse

Personalized cancer immunotherapy targeting patient-specific cancer/testis antigens (CTA) and neoantigens may benefit from large-scale tumor human leukocyte antigen (HLA) peptidome (immunopeptidome) analysis, which aims to accurately identify antigens presented by tumor cells. Although significant e...

Descripción completa

Detalles Bibliográficos
Autores principales: Rijensky, Nataly Mancette, Blondheim Shraga, Netta R., Barnea, Eilon, Peled, Nir, Rosenbaum, Eli, Popovtzer, Aron, Stemmer, Solomon M., Livoff, Alejandro, Shlapobersky, Mark, Moskovits, Neta, Perry, Dafna, Rubin, Eitan, Haviv, Itzhak, Admon, Arie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015002/
https://www.ncbi.nlm.nih.gov/pubmed/32451349
http://dx.doi.org/10.1074/mcp.RA119.001876

Ejemplares similares

Ejemplares similares